|
Jul 31
|
Microsoft Q4 Earnings & Revenues Beat on Cloud Business Expansion
|
|
Jul 28
|
Josh Brown on Pfizer (PFE): ‘I Was Dead Wrong, There’s No Turnaround’
|
|
Jul 28
|
Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.
|
|
Jul 28
|
Ireland's 'economic miracle' at risk from tariffs
|
|
Jul 28
|
Vascarta Announces Addition of Dr. Janet Loesberg to Leadership Team
|
|
Jul 28
|
Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?
|
|
Jul 27
|
Pfizer Inc. (PFE) Finalizes Global Licensing Agreement with 3sbio, Inc.
|
|
Jul 26
|
Pfizer (PFE) Receives CHMP Recommendation For Adapted COVID-19 Vaccine COMIRNATY
|
|
Jul 25
|
Metastatic Hormone Refractory Prostate Cancer Pipeline Market Research Report 2025 | In-depth Analysis of 180+ Companies and Over 200 Drugs in Development
|
|
Jul 25
|
Pfizer and 3SBio conclude licensing deal for SSGJ-707
|
|
Jul 25
|
Post-Operative Nausea and Vomiting Market Report 2025: Surge in Surgical Procedures Fuels $2.97 Billion Growth in PONV Market by 2029
|
|
Jul 25
|
GM Is Loading Up on Its Own Shares. Investors Should Follow Suit.
|
|
Jul 25
|
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
|
|
Jul 25
|
Zoetis (ZTS): Buy, Sell, or Hold Post Q1 Earnings?
|
|
Jul 25
|
Truist Sees Upside in BridgeBio Pharma’s (BBIO) ATTR-CM Strategy
|
|
Jul 24
|
AI Investment Is Already Huge. Google, Trump Show Much More Is Coming.
|
|
Jul 24
|
Pfizer (PFE) Faces Legal Challenges Over Depo-Provera's Increased Brain Tumor Risk
|
|
Jul 24
|
Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices
|
|
Jul 24
|
Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?
|
|
Jul 24
|
How Will Eli Lilly's Oncology Drugs Perform in Q2 Earnings?
|